| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO And President | See Remarks +1 more
1 company
Shaff Eric D. is a Director at Seres Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $80K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2019 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,378 | $5.75 | $25,187.51 | -25.4% | |
| Jan 26, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 2,780 | $11.02 | $30,635.60 | -34.8% | |
| Jun 30, 2016 | MCRB Seres Therapeutics, Inc. | CFO And EVP | Sale+OE | 4,533 | $29.54 | $133,904.82 | -100% | |
| Jun 28, 2016 | MCRB Seres Therapeutics, Inc. | CFO And EVP | Sale+OE | 5,001 | $28.28 | $141,444.95 | -100% | |
| Apr 4, 2016 | MCRB Seres Therapeutics, Inc. | CFO And EVP | Sale+OE | 6,568 | $28.85 | $189,486.80 | -100% | |
| Mar 31, 2016 | MCRB Seres Therapeutics, Inc. | CFO And EVP | Sale+OE | 7,663 | $26.30 | $201,569.35 | -53.8% | |
| Mar 28, 2016 | MCRB Seres Therapeutics, Inc. | CFO And EVP | Sale+OE | 5,473 | $24.07 | $131,735.11 | -100% |